A retrospective analysis of 24-month real-world glucose control for children and adolescents with type 1 diabetes using the MiniMed™ 670G insulin pump

Affiliations

¹ Metabolic Disease and Genetic Unit, "Giovanni XXIII" Children Hospital, AOU Policlinico di Bari, Bari, Italy.
² Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
³ Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy.
⁴ Pediatric Diabetes, San Raffaele Scientific Hospital and Vita Salute San Raffaele University, Milan, Italy.
⁵ Pediatric Department, S. Chiara Hospital of Trento, Trento, Italy.
⁶ Department of Pediatrics, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
⁷ Pediatric Department, Maggiore Hospital of Crema, Crema, Italy.
⁸ Regional Center for Pediatric Diabetes, Department of Pediatrics, University of the Study of Campania, Naples, Italy.
⁹ Pediatric Hospital, SS Antonio and Biagio and Cesare Arrigo, Alessandria, Italy.

Free article

Maurizio Delvecchio et al. Diabetes Obes Metab. 2023 Apr.

Free article

. 2023 Apr;25(4):1101-1105.

doi: 10.1111/dom.14934. Epub 2022 Dec 22.

¹ Metabolic Disease and Genetic Unit, "Giovanni XXIII" Children Hospital, AOU Policlinico di Bari, Bari, Italy.
² Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
³ Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy.
⁴ Pediatric Diabetes, San Raffaele Scientific Hospital and Vita Salute San Raffaele University, Milan, Italy.
⁵ Pediatric Department, S. Chiara Hospital of Trento, Trento, Italy.
⁶ Department of Pediatrics, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.
⁷ Pediatric Department, Maggiore Hospital of Crema, Crema, Italy.
⁸ Regional Center for Pediatric Diabetes, Department of Pediatrics, University of the Study of Campania, Naples, Italy.
⁹ Pediatric Hospital, SS Antonio and Biagio and Cesare Arrigo, Alessandria, Italy.

No abstract available

Keywords: CSII; continuous glucose monitoring (CGM); insulin pump therapy; realworld evidence; type 1 diabetes.

References

1. Piona C, Marigliano M, Mozzillo E, et al. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: determination of optimal sampling duration. Pediatr Diabetes. 2020;21(8):1485-1492. doi:10.1111/pedi.13115
1. Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose outcomes with the In-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155-163. doi:10.1089/dia.2016.0421
1. Messer LH, Forlenza GP, Sherr JL, et al. Hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system. Diabetes Care. 2018;41(4):789-796. doi:10.2337/dc17-1682
1. Forlenza GP, Pinhas-Hamiel O, Liljenquist DR, et al. Safety evaluation of the MiniMed 670G system in children 7-13 years of age with type 1 diabetes. Diabetes Technol Ther. 2019;21(1):11-19. doi:10.1089/dia.2018.0264
1. Berget C, Messer LH, Vigers T, et al. Six months of hybrid closed loop in the real-world: an evaluation of children and young adults using the 670G system. Pediatr Diabetes. 2020;21(2):310-318. doi:10.1111/pedi.12962